U.S. Centers for Disease Control and Prevention
Medical News
Paradigm Shift for HIV Prevention in the United States
June 18, 2002
Men who have sex with men (MSM) have been disproportionately
represented throughout the HIV/AIDS epidemic in the United
States. MSM and their communities are credited with making major
reductions in and sustaining relatively low levels of risky
sexual behavior for many years during the 1980s and perhaps into
the 1990s. Indicators since the mid-1990s, however, suggest a
potential resurgence of HIV infections among MSM in the United
States.
Distinguishing between epidemics
Before the widespread use of effective antiretroviral
treatments, HIV/AIDS in the United States was viewed largely as an
AIDS epidemic. Death rates were relatively high and the incidence
of risky sexual behavior was relatively low among MSM, who were in
danger of acquiring a terminal disease that progressed to death
within several years. Since HAART became available in the mid-
1990s, HIV/AIDS has come to be viewed more like a chronic disease.
Although HIV treatments are not effective for, adhered to, or
tolerated by everyone over time, many promising new drugs are
being developed, so a relatively low incidence of AIDS deaths may
continue in the future. The HIV epidemic now faces challenges that
other preventable chronic diseases (e.g., heart disease, diabetes)
similarly rooted in behavior choices have faced for decades. The
challenge for prevention is that people appear to be more likely
to knowingly put themselves at risk for a disease if morbidity and
mortality from that disease are relatively distant outcomes.
Many MSM, HIV-negative as well as HIV-positive, acknowledge
that their risky behavior has increased as a result of the
availability of HAART. Gay and bisexual men report that HIV
treatments relieve their worries about unsafe sex. For some MSM
at some times, other needs (e.g., physical stimulation, emotional
connection) may be equally or more important than preventing HIV
infection.
Current biomedical preventions
The shift from an AIDS epidemic to an HIV epidemic in the
United States poses a scientific challenge for assessing and
subsequently disseminating effective vaccines and microbicides.
Research indicates that the willingness to participate in vaccine
trials may be associated with risky sexual behavior and, further,
that MSM participants who perceive that they are in the vaccine
arm of a clinical trial (compared to MSM who perceive that they
are in the placebo arm or who are unsure) report higher rates of
risky sexual behavior during the study. Similar results were
reported from a feasibility study of a hypothetical microbicide
product for rectal use.
Paradigm shift for prevention
HIV prevention strategies for MSM, by and large, have not
changed to reflect the dramatic shift in the epidemic. A shift in
HIV prevention is needed on two main fronts.
Advertisement
Tandem biomedical and behavioral prevention are needed. It is
believed that early generations of available vaccines and
microbicides will be less effective than condoms -- estimated to be
approximately 90 percent to 95 percent effective -- so condom use
will continue to be the prevention standard and a primary
component of prevention messages. More behavioral research is
needed to develop effective multicomponent prevention messages in
preparation for a partially effective vaccine or microbicide. As a
simple example, how might the following multicomponent message
translate into behavior at the population level? "Used correctly,
product X may be protective against HIV infection 50% of the time
during anal sex, and condoms may be protective against HIV
infection 95% of the time."
Behavioral interventions are needed to reduce the risk for HIV
infection in the era of an HIV epidemic. Thus, research is needed
to develop multicomponent prevention messages that incorporate
effective behavioral strategies that MSM may already be using. One
example is "Use a condom unless you are in the context of
'negotiated safety' (i.e., an HIV-concordant primary partnership
in which partners are periodically tested for HIV, agree to no
risk behavior outside the partnership, and participate in ongoing
reassessment of this agreement)." Multicomponent messages may
dilute the primary message and prevention standard (i.e., always
use a condom); however, acknowledging effective strategies with
specific guidelines may not only provide options directly but may
also enhance the credibility of message senders and indirectly
increase condom use. In addition, behavioral research is needed to
assess entirely new approaches to HIV prevention in a chronic
disease epidemic.
These new approaches could be described as a shift from
disease prevention in an AIDS epidemic to health promotion in an
HIV epidemic. Rather than a single, specific disease prevention
program, broad health promotion and healthy lifestyle programs may
be beneficial. Broad health promotion programs would address HIV
prevention in the context of other important health issues (e.g.,
substance use, depression, personal safety), promoting a general
approach to health decision-making in one's life. In fact, there
is evidence that health behaviors may be linked; that is, broad
health promotion or healthy lifestyle programs may work to prevent
chronic diseases and other health concerns.
"As responsive scientists, prevention specialists, and health
officials, we must heed the call for change and work alongside MSM
communities for a successful shift in HIV prevention that reflects
the epidemiologic shift that has become a reality," the report
concluded.
Excerpted from: AIDScience 05.24.02; Vol. 2; No. 10: P. 1-5; Gordon ManserghThis article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.